Influence of an eicosapentaenoic and docosahexaenoic acid-enriched enteral nutrition formula on plasma fatty acid composition and biomarkers of insulin resistance in the elderly

Clin Nutr. 2010 Feb;29(1):31-7. doi: 10.1016/j.clnu.2009.06.003. Epub 2009 Jul 1.

Abstract

Background & aims: n-3 Polyunsaturated fatty acids may improve cardiovascular outcomes in elderly. The aim of this study was to determine the effect of feeding elderly patients exclusively with an n-3 polyunsaturated fatty acid-enriched diet specifically designed for enteral nutrition for 6 months, evaluating modifications in plasma fatty acid profile and some biomarkers of insulin resistance (IR).

Methods: Thirty-two patients >65 years were fed a new enteral formula (T-Diet Plus) containing 75 mg/l of eicosapentaenoic acid (EPA) and 35 mg/l of docosahexaenoic acid (DHA) and 33 were fed an enteral diet intended for elderly (Jevity). Blood samples were drawn at the beginning and after 3 and 6 months of feeding. Plasma lipids, total plasma and lipid fraction fatty acid profiles, and some IR-associated adipokines were analysed.

Results: Feeding on T-Diet Plus allowed EPA and DHA incorporation into plasma lipids and normalised blood triacylglycerols (TAG) levels after 3 months without major changes in IR, leptin and adiponectin.

Conclusions: Feeding the elderly exclusively with an enteral formula enriched with EPA and DHA improves their plasma lipid fatty acid profile and lowers TAG, a well known cardiovascular risk biomarker, without affecting IR.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anthropometry / methods
  • Biomarkers / blood
  • Blood Glucose
  • Body Composition
  • Diet / methods
  • Dietary Supplements*
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / pharmacology*
  • Docosahexaenoic Acids / therapeutic use
  • Eicosapentaenoic Acid / administration & dosage
  • Eicosapentaenoic Acid / pharmacology*
  • Eicosapentaenoic Acid / therapeutic use
  • Enteral Nutrition / methods*
  • Fatty Acids, Omega-3 / blood*
  • Female
  • Follow-Up Studies
  • Geriatric Assessment / methods
  • Humans
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Male
  • Prospective Studies
  • Risk Factors
  • Skinfold Thickness
  • Spain

Substances

  • Biomarkers
  • Blood Glucose
  • Fatty Acids, Omega-3
  • Insulin
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid